Biosafety, What Is Regulated in the Cartagena Protocol?

Biosafety is closely related to natural events, such as outbreaks, epidemics and pandemics. Biosafety can also be related to accidents in the laboratory or work area, which can be caused by containment failures, engineering failures of the facilities used, or the behavior of the working personnel.
Biosafety is an effort made to protect humans and the environment from elements derived from biological materials. Biosafety aims to reduce or eliminate the exposure of an individual or the environment to hazardous biological agents. This is achieved by implementing various levels of laboratory and room control (containment) through laboratory design and access restrictions, capacity building and training, use of containment equipment and safe methods for handling infectious materials within the laboratory environment.
Biosafety has been regulated in the Cartegena Protocol, and Indonesia is one of the countries implementing the protocol. The Cartagena Protocol is a continuation of the convention on biodiversity in Rio De Jainero, Brazil in 1992.

What things are set in the protocol?

In the convention, in Article 8 letter (g), article 17, article 19 paragraph (3) and paragraph (4) mandates further regulation regarding cross-border arrangements, procurement and utilization of genetically modified organisms as a result of modern biotechnology. With this mandate came a protocol agreed in Cartagena, Colombia in 2000.
The Cartagena Protocol is an agreement of the parties to regulate cross-border activities or stopovers, handling and utilization of living organisms produced by modern biotechnology from one country to another by a person or institution. The level of biosafety protection is carried out to avoid negative impacts on the preservation and sustainable use of biodiversity and risks to human health.